Praxis Precision Medicines Provides Corporate Update and Reports Second Quarter 2026 Financial Results

Go back to Praxis Precision Medicines Provides Corporate Update and Reports Second Quarter 2026 Financial Results
(NASDAQ: PRAX) Delayed: 298.95 --0 (-0%)
Previous Close $298.95    52 Week High
Open $298.95    52 Week Low
Day High $298.95    P/E N/A 
Day Low $298.95    EPS
Volume 34